Related references
Note: Only part of the references are listed.Reductive Amination Routes in the Synthesis of Piperidine IminoSugars
Francesca Clemente et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2020)
Glucocerebrosidase (GCase) activity modulation by 2-alkyl trihydroxypiperidines: Inhibition and pharmacological chaperoning
F. Clemente et al.
BIOORGANIC CHEMISTRY (2020)
Migalastat: A Review in Fabry Disease
Emma H. McCafferty et al.
DRUGS (2019)
Stereoselective Synthesis of C-2 Alkylated Trihydroxypiperidines: Novel Pharmacological Chaperones for Gaucher Disease
Francesca Clemente et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Lysosomal storage disorders - challenges, concepts and avenues for therapy: beyond rare diseases
Andre R. A. Marques et al.
JOURNAL OF CELL SCIENCE (2019)
Biological activities of 3,4,5-trihydroxypiperidines and their N- and O-derivatives
Kate Prichard et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2018)
Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element
Anushka C. Galasiti Kankanamalage et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones
David M. Pereira et al.
CHEMICAL SCIENCE (2018)
4-epi-Isofagomine derivatives as pharmacological chaperones for the treatment of lysosomal diseases linked to beta-galactosidase mutations: Improved synthesis and biological investigations
Sophie Front et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Lysosomal storage diseases
Frances M. Platt et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
(5aR)-5a-C-Pentyl-4-epi-isofagomine: A powerful inhibitor of lysosomal β-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type
Sophie Front et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Accessing 2-substituted piperidine iminosugars by organometallic addition/intramolecular reductive amination: aldehyde vs. nitrone route
S. Mirabella et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2017)
Iminosugar-based ceramide mimicry for the design of new CERT START domain ligands
Cecile Santos et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Pharmacological Chaperones: Design and Development of New Therapeutic Strategies for the Treatment of Conformational Diseases
Marino Convertino et al.
ACS CHEMICAL BIOLOGY (2016)
Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, G(M1)-gangliosidosis and Fabry diseases
Elena M. Sanchez-Fernandez et al.
CHEMICAL COMMUNICATIONS (2016)
Docking study and biological evaluation of pyrrolidine-based iminosugars as pharmacological chaperones for Gaucher disease
Atsushi Kato et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2016)
Lysosomal Storage Diseases: From Pathophysiology to Therapy
Giancarlo Parenti et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Human Acid β-Glucosidase Inhibition by Carbohydrate Derived Iminosugars: Towards New Pharmacological Chaperones for Gaucher Disease
Camilla Parmeggiani et al.
CHEMBIOCHEM (2015)
Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders
Giancarlo Parenti et al.
MOLECULAR THERAPY (2015)
Iminosugar-Based Galactoside Mimics as Inhibitors of Galactocerebrosidase: SAR Studies and Comparison with Other Lysosomal Galactosidases
Anna Biela-Banas et al.
CHEMMEDCHEM (2014)
Polyhydroxyamino-Piperidine-Type Iminosugars and Pipecolic Acid Analogues from a D-Mannose-Derived Aldehyde
Camilla Matassini et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2014)
Synthesis of 1,5-Dideoxy-1,5-iminoribitol C-Glycosides through a Nitrone-Olefin Cycloaddition Domino Strategy: Identification of Pharmacological Chaperones of Mutant Human Lysosomal β-Galactosidase
Aloysius Siriwardena et al.
JOURNAL OF ORGANIC CHEMISTRY (2014)
Treatment of Lysosomal Storage Diseases: Recent Patents and Future Strategies
Saida Ortolano et al.
RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY (2014)
Pharmacological Chaperones as Therapeutics for Lysosomal Storage Diseases
Robert E. Boyd et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Tuning glycosidase inhibition through aglycone interactions: pharmacological chaperones for Fabry disease and GM1 gangliosidosis
M. Aguilar-Moncayo et al.
CHEMICAL COMMUNICATIONS (2012)
Double Reductive Amination and Selective Strecker Reaction of a D-Lyxaric Aldehyde: Synthesis of Diversely Functionalized 3,4,5-Trihydroxypiperidines
Camilla Matassini et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2012)
Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy
Brigitte A. Rigat et al.
MOLECULAR GENETICS AND METABOLISM (2012)
GM1 gangliosidosis and Morquio B disease: An update on genetic alterations and clinical findings
Anna Caciotti et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Second-Generation Iminoxylitol-Based Pharmacological Chaperones for the Treatment of Gaucher Disease
Farah Oulaidi et al.
CHEMMEDCHEM (2011)
GM1 gangliosidosis:: Review of clinical, molecular, and therapeutic aspects
Nicola Brunetti-Pierri et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Design and synthesis of highly potent and selective pharmacological chaperones for the treatment of Gaucher's disease
Philippe Compain et al.
CHEMBIOCHEM (2006)
Olefination of ketones using a gold(III)-catalyzed Meyer-Schuster rearrangement
Douglas A. Engel et al.
ORGANIC LETTERS (2006)
Chemical chaperone therapy for brain pathology in GM1-gangliosidosis
J Matsuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation
HR Mellor et al.
BIOCHEMICAL JOURNAL (2003)
Solvation effects in the Grignard reaction with carbonyl compounds
M Sassian et al.
HELVETICA CHIMICA ACTA (2003)
Preparation, biochemical characterization and biological properties of radiolabelled N-alkylated deoxynojirimycins
HR Mellor et al.
BIOCHEMICAL JOURNAL (2002)
Share Paper
